|
OMIM |
Link |
Information gain |
01 |
|
blood group--lutheran inhibitor
|
[NCBI]
|
0.00387299
|
|
|
MF4
|
[NCBI]
|
0.00179948
|
|
|
UL
|
[NCBI]
|
0.00179948
|
|
|
LKE
|
[NCBI]
|
0.00179948
|
|
|
fingerprints, absence of
|
[NCBI]
|
0.00179948
|
|
|
acromial dimples
|
[NCBI]
|
0.00179948
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.00179948
|
|
|
lipoprotein types--ld system
|
[NCBI]
|
0.00179948
|
|
|
adenosine triphosphatase deficiency, anemia due to
|
[NCBI]
|
0.00179948
|
|
|
hyperpigmentation, familial progressive
|
[NCBI]
|
0.00179948
|
|
|
Sf
|
[NCBI]
|
0.00179948
|
|
|
AN
|
[NCBI]
|
0.00179948
|
|
|
salivary substance, clostridium botulinum type
|
[NCBI]
|
0.00179948
|
|
|
koilonychia, hereditary
|
[NCBI]
|
0.00179948
|
|
|
letterer-siwe disease
|
[NCBI]
|
0.00179948
|
|
|
molar i reinclusion
|
[NCBI]
|
0.00127937
|
|
|
AKE
|
[NCBI]
|
0.00127937
|
|
|
ASD1
|
[NCBI]
|
0.00127937
|
|
|
thrombasthenia-thrombocytopenia, hereditary
|
[NCBI]
|
0.00127937
|
|
|
MAFD2
|
[NCBI]
|
0.00121196
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.00108503
|
|
|
precocious puberty
|
[NCBI]
|
0.00108503
|
|
|
cowchock syndrome
|
[NCBI]
|
0.00108503
|
|
|
xm system
|
[NCBI]
|
0.00108503
|
|
|
OPA2
|
[NCBI]
|
0.00108503
|
|
|
blood group, p system
|
[NCBI]
|
0.000997767
|
|
|
SC
|
[NCBI]
|
0.000964963
|
|
|
DFN2
|
[NCBI]
|
0.000959946
|
|
|
AQP1
|
[NCBI]
|
0.000915664
|
|
|
CO
|
[NCBI]
|
0.000906505
|
|
|
OTSC1
|
[NCBI]
|
0.000867747
|
|
|
CDAN3
|
[NCBI]
|
0.000867747
|
|
|
DI
|
[NCBI]
|
0.000776687
|
|
|
SW
|
[NCBI]
|
0.000776687
|
|
|
RA
|
[NCBI]
|
0.000661436
|
|
|
YT
|
[NCBI]
|
0.000646976
|
|
|
blood group--froese
|
[NCBI]
|
0.00051737
|
|
|
CGD
|
[NCBI]
|
0.000476964
|
|
|
IN
|
[NCBI]
|
0.000460431
|
|
|
CDAN2
|
[NCBI]
|
0.000414778
|
|
|
Ge
|
[NCBI]
|
0.000393669
|
|
|
FY
|
[NCBI]
|
0.000388017
|
|
|
SLE
|
[NCBI]
|
0.000383237
|
|
|
ART4
|
[NCBI]
|
0.000345014
|
|
|
RD
|
[NCBI]
|
0.00033669
|
|
|
CF
|
[NCBI]
|
0.000310867
|
|
|
GC
|
[NCBI]
|
0.000293737
|
|
|
XG
|
[NCBI]
|
0.00029232
|
|
|
thiourea tasting
|
[NCBI]
|
0.000281061
|
|
|
CZP1
|
[NCBI]
|
0.000279246
|
|
|
XK
|
[NCBI]
|
0.000268701
|
|
|
alkaline phosphatase, blood group-associated
|
[NCBI]
|
0.000258476
|
|
|
WD
|
[NCBI]
|
0.000258476
|
|
|
Ii
|
[NCBI]
|
0.000228616
|
|
|
ERMAP
|
[NCBI]
|
0.000213353
|
|
|
HLA-A
|
[NCBI]
|
0.000211782
|
|
|
raph blood group system
|
[NCBI]
|
0.00019545
|
|
|
JK
|
[NCBI]
|
0.000184629
|
|
|
CMT1B
|
[NCBI]
|
0.000172556
|
|
|
VWS
|
[NCBI]
|
0.000170099
|
|
|
ED1
|
[NCBI]
|
0.000170099
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.000170099
|
|
|
RHCE
|
[NCBI]
|
0.000167162
|
|
|
australia antigen
|
[NCBI]
|
0.000156429
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000151277
|
|
|
RHN
|
[NCBI]
|
0.000150384
|
|
|
KEL
|
[NCBI]
|
0.00014999
|
|
|
THC1
|
[NCBI]
|
0.000140328
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
0.000140328
|
|
|
PGM1
|
[NCBI]
|
0.00013632
|
|
|
blood group--private systems
|
[NCBI]
|
0.000129186
|
|
|
gil blood group
|
[NCBI]
|
0.000129186
|
|
|
NFLD
|
[NCBI]
|
0.000129186
|
|
|
larynx, congenital partial atresia of
|
[NCBI]
|
0.000129186
|
|
|
lutheran null
|
[NCBI]
|
0.000129186
|
|
|
WR
|
[NCBI]
|
0.000129186
|
|
|
ovalocytosis, hereditary hemolytic
|
[NCBI]
|
0.000129186
|
|
|
sc(1) trait of saliva
|
[NCBI]
|
0.000129186
|
|
|
asthma, short stature, and elevated iga
|
[NCBI]
|
0.000129186
|
|
|
blood group--public systems
|
[NCBI]
|
0.000129186
|
|
|
blood group--en
|
[NCBI]
|
0.000129186
|
|
|
woronets trait
|
[NCBI]
|
0.000129186
|
|
|
LU
|
[NCBI]
|
0.000124618
|
|
|
SLC4A1
|
[NCBI]
|
0.000123839
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
0.000118249
|
|
|
C4B
|
[NCBI]
|
0.0001161
|
|
|
CCAL2
|
[NCBI]
|
0.000114112
|
|
|
DMD
|
[NCBI]
|
0.000113427
|
|
|
OCRL
|
[NCBI]
|
0.000109462
|
|
|
meningioma, familial
|
[NCBI]
|
0.000109462
|
|
|
MN
|
[NCBI]
|
0.0001011
|
|
|
CMTX1
|
[NCBI]
|
9.96765e-05
|
|
|
ACP1
|
[NCBI]
|
9.95116e-05
|
|
|
KN
|
[NCBI]
|
9.76733e-05
|
|
|
CD99
|
[NCBI]
|
9.567e-05
|
|
|
FUT1
|
[NCBI]
|
9.40778e-05
|
|
|
HP
|
[NCBI]
|
9.22282e-05
|
|
|
FUT2
|
[NCBI]
|
8.75379e-05
|
|
|
fabry disease
|
[NCBI]
|
8.65614e-05
|
|
|
mixed lymphocyte culture locus ii
|
[NCBI]
|
8.58281e-05
|
|
|
chromosome 18p deletion syndrome
|
[NCBI]
|
8.58281e-05
|
|
|
surface antigen, glycoprotein 75
|
[NCBI]
|
8.58281e-05
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
8.58281e-05
|
|
|
LW
|
[NCBI]
|
8.43584e-05
|
|
|
HPA-2
|
[NCBI]
|
8.10375e-05
|
|
|
NPS
|
[NCBI]
|
7.8375e-05
|
|
|
XS
|
[NCBI]
|
7.81633e-05
|
|
|
AQP3
|
[NCBI]
|
7.64369e-05
|
|
|
CHM
|
[NCBI]
|
7.44447e-05
|
|
|
CRS1
|
[NCBI]
|
7.2484e-05
|
|
|
mast cell disease
|
[NCBI]
|
7.2484e-05
|
|
|
watson syndrome
|
[NCBI]
|
7.2484e-05
|
|
|
CD55
|
[NCBI]
|
7.21489e-05
|
|
|
ND
|
[NCBI]
|
7.17377e-05
|
|
|
SPG17
|
[NCBI]
|
6.79741e-05
|
|
|
HDL2
|
[NCBI]
|
6.42369e-05
|
|
|
SEDT
|
[NCBI]
|
6.42369e-05
|
|
|
CMAH
|
[NCBI]
|
6.42369e-05
|
|
|
JBS
|
[NCBI]
|
6.42369e-05
|
|
|
C3
|
[NCBI]
|
6.35109e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
6.28105e-05
|
|
|
AMY2A
|
[NCBI]
|
6.23432e-05
|
|
|
PGD
|
[NCBI]
|
6.14554e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
6.10489e-05
|
|
|
reifenstein syndrome
|
[NCBI]
|
6.10489e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
6.10489e-05
|
|
|
pulmonary edema of mountaineers
|
[NCBI]
|
6.10489e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
5.82715e-05
|
|
|
DYX1
|
[NCBI]
|
5.82715e-05
|
|
|
IHCM
|
[NCBI]
|
5.82715e-05
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
5.82715e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
5.58129e-05
|
|
|
AHDS
|
[NCBI]
|
5.58129e-05
|
|
|
VEGF
|
[NCBI]
|
5.56042e-05
|
|
|
THC2
|
[NCBI]
|
5.36089e-05
|
|
|
CDPX1
|
[NCBI]
|
5.36089e-05
|
|
|
EDM1
|
[NCBI]
|
5.36089e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
5.36089e-05
|
|
|
B4GALNT2
|
[NCBI]
|
5.30582e-05
|
|
|
GPI
|
[NCBI]
|
5.25681e-05
|
|
|
SPG2
|
[NCBI]
|
5.1613e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
5.1613e-05
|
|
|
leopard syndrome 1
|
[NCBI]
|
4.97904e-05
|
|
|
IFD
|
[NCBI]
|
4.97904e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
4.81144e-05
|
|
|
JH
|
[NCBI]
|
4.81144e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
4.68065e-05
|
|
|
MADA
|
[NCBI]
|
4.65639e-05
|
|
|
PMC
|
[NCBI]
|
4.65639e-05
|
|
|
TTDP
|
[NCBI]
|
4.65639e-05
|
|
|
ALB
|
[NCBI]
|
4.64988e-05
|
|
|
C4A
|
[NCBI]
|
4.61672e-05
|
|
|
LAG5
|
[NCBI]
|
4.55771e-05
|
|
|
CDG2C
|
[NCBI]
|
4.51222e-05
|
|
|
pfeiffer syndrome
|
[NCBI]
|
4.51222e-05
|
|
|
xanthinuria, type i
|
[NCBI]
|
4.37756e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
4.37756e-05
|
|
|
A4GALT
|
[NCBI]
|
4.31912e-05
|
|
|
pituitary dwarfism i
|
[NCBI]
|
4.2513e-05
|
|
|
DKC
|
[NCBI]
|
4.13249e-05
|
|
|
FUT3
|
[NCBI]
|
4.12471e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
4.02036e-05
|
|
|
EL1
|
[NCBI]
|
3.91424e-05
|
|
|
MG
|
[NCBI]
|
3.84081e-05
|
|
|
RP3
|
[NCBI]
|
3.71779e-05
|
|
|
GCPS
|
[NCBI]
|
3.71779e-05
|
|
|
BPES
|
[NCBI]
|
3.62654e-05
|
|
|
CCT
|
[NCBI]
|
3.55209e-05
|
|
|
yeast factor
|
[NCBI]
|
3.55209e-05
|
|
|
TF
|
[NCBI]
|
3.4582e-05
|
|
|
PFIC1
|
[NCBI]
|
3.45611e-05
|
|
|
AHC
|
[NCBI]
|
3.45611e-05
|
|
|
OA1
|
[NCBI]
|
3.38985e-05
|
|
|
CHAC
|
[NCBI]
|
3.37631e-05
|
|
|
SPDA1
|
[NCBI]
|
3.29975e-05
|
|
|
CBD
|
[NCBI]
|
3.26575e-05
|
|
|
WS1
|
[NCBI]
|
3.22621e-05
|
|
|
RTS
|
[NCBI]
|
3.22621e-05
|
|
|
obesity
|
[NCBI]
|
3.15548e-05
|
|
|
IGKC
|
[NCBI]
|
3.05497e-05
|
|
|
RP2
|
[NCBI]
|
3.02369e-05
|
|
|
IGER
|
[NCBI]
|
3.02171e-05
|
|
|
TGD
|
[NCBI]
|
3.02171e-05
|
|
|
FCAS
|
[NCBI]
|
3.02171e-05
|
|
|
AK1
|
[NCBI]
|
2.96386e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
2.93521e-05
|
|
|
BMD
|
[NCBI]
|
2.89715e-05
|
|
|
ABO
|
[NCBI]
|
2.88022e-05
|
|
|
KAL1
|
[NCBI]
|
2.88022e-05
|
|
|
CLN3
|
[NCBI]
|
2.78073e-05
|
|
|
aHUS
|
[NCBI]
|
2.61945e-05
|
|
|
IGHG4
|
[NCBI]
|
2.53095e-05
|
|
|
TBG
|
[NCBI]
|
2.46844e-05
|
|
|
MUC1
|
[NCBI]
|
2.46779e-05
|
|
|
antigen defined by monoclonal antibody f10.44.2
|
[NCBI]
|
2.34969e-05
|
|
|
BLM
|
[NCBI]
|
2.33658e-05
|
|
|
SLOS
|
[NCBI]
|
2.30995e-05
|
|
|
PRKAR1B
|
[NCBI]
|
2.21509e-05
|
|
|
MIC2Y
|
[NCBI]
|
2.21509e-05
|
|
|
alkaline phosphatase, elevated serum
|
[NCBI]
|
2.21509e-05
|
|
|
lynch syndrome i
|
[NCBI]
|
2.13325e-05
|
|
|
CHE2
|
[NCBI]
|
2.10797e-05
|
|
|
B3GALNT1
|
[NCBI]
|
2.01901e-05
|
|
|
LNPEP
|
[NCBI]
|
2.01901e-05
|
|
|
LNS
|
[NCBI]
|
1.95329e-05
|
|
|
SEMA7A
|
[NCBI]
|
1.87654e-05
|
|
|
PEPC
|
[NCBI]
|
1.87654e-05
|
|
|
SCZD
|
[NCBI]
|
1.85478e-05
|
|
|
PSORS1
|
[NCBI]
|
1.82336e-05
|
|
|
GCNT2
|
[NCBI]
|
1.81763e-05
|
|
|
SRA2
|
[NCBI]
|
1.81763e-05
|
|
|
PI
|
[NCBI]
|
1.78649e-05
|
|
|
CD151
|
[NCBI]
|
1.76469e-05
|
|
|
Ss
|
[NCBI]
|
1.76469e-05
|
|
|
EGFR
|
[NCBI]
|
1.75566e-05
|
|
|
WT1
|
[NCBI]
|
1.73299e-05
|
|
|
OCP
|
[NCBI]
|
1.73299e-05
|
|
|
ESD
|
[NCBI]
|
1.70895e-05
|
|
|
CBP
|
[NCBI]
|
1.67267e-05
|
|
|
JARID1D
|
[NCBI]
|
1.59457e-05
|
|
|
ICAM5
|
[NCBI]
|
1.59457e-05
|
|
|
WRN
|
[NCBI]
|
1.59421e-05
|
|
|
APOA2
|
[NCBI]
|
1.55955e-05
|
|
|
AVP
|
[NCBI]
|
1.52475e-05
|
|
|
FCGR3A
|
[NCBI]
|
1.49595e-05
|
|
|
PGM3
|
[NCBI]
|
1.43939e-05
|
|
|
NCSTN
|
[NCBI]
|
1.43939e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.41313e-05
|
|
|
ALPP
|
[NCBI]
|
1.36486e-05
|
|
|
F12
|
[NCBI]
|
1.36486e-05
|
|
|
pta deficiency
|
[NCBI]
|
1.36486e-05
|
|
|
RHD
|
[NCBI]
|
1.34228e-05
|
|
|
menkes disease
|
[NCBI]
|
1.33194e-05
|
|
|
GLO1
|
[NCBI]
|
1.28004e-05
|
|
|
GJA8
|
[NCBI]
|
1.28004e-05
|
|
|
DMD
|
[NCBI]
|
1.26122e-05
|
|
|
ITGA2B
|
[NCBI]
|
1.24248e-05
|
|
|
CD44
|
[NCBI]
|
1.22472e-05
|
|
|
phenylketonuria
|
[NCBI]
|
1.18408e-05
|
|
|
BCNS
|
[NCBI]
|
1.17103e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
1.14439e-05
|
|
|
SHOX
|
[NCBI]
|
1.12979e-05
|
|
|
FRDA
|
[NCBI]
|
1.11606e-05
|
|
|
APOC2
|
[NCBI]
|
1.10185e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.08088e-05
|
|
|
AHO
|
[NCBI]
|
1.04681e-05
|
|
|
fucosidosis
|
[NCBI]
|
1.02659e-05
|
|
|
LPA
|
[NCBI]
|
9.92992e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
9.82302e-06
|
|
|
HS
|
[NCBI]
|
9.41822e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
9.0607e-06
|
|
|
UMOD
|
[NCBI]
|
8.70131e-06
|
|
|
PGK1
|
[NCBI]
|
8.6191e-06
|
|
|
APCS
|
[NCBI]
|
8.45902e-06
|
|
|
SPTA1
|
[NCBI]
|
8.38106e-06
|
|
|
MTND4
|
[NCBI]
|
8.38106e-06
|
|
|
NP
|
[NCBI]
|
8.22909e-06
|
|
|
AQP4
|
[NCBI]
|
8.15499e-06
|
|
|
HBD
|
[NCBI]
|
7.73465e-06
|
|
|
AQP2
|
[NCBI]
|
7.47524e-06
|
|
|
AFP
|
[NCBI]
|
7.40566e-06
|
|
|
BTK
|
[NCBI]
|
7.11315e-06
|
|
|
GNAS
|
[NCBI]
|
6.00224e-06
|
|
|
HPRT1
|
[NCBI]
|
5.13411e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
5.09899e-06
|
|
|
ACHE
|
[NCBI]
|
4.61539e-06
|
|
|
RB1
|
[NCBI]
|
4.51862e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
4.4753e-06
|
|
|
HBB
|
[NCBI]
|
3.99867e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.9279e-06
|
|
|
HEMB
|
[NCBI]
|
3.43505e-06
|
|
|
HFE
|
[NCBI]
|
3.41376e-06
|
|
|
AIS
|
[NCBI]
|
3.3938e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
2.96062e-06
|
|
|
FMF
|
[NCBI]
|
2.56789e-06
|
|
|
AR
|
[NCBI]
|
2.33906e-06
|
|
|
G6PD
|
[NCBI]
|
1.98073e-06
|
|
|
EPO
|
[NCBI]
|
1.86154e-06
|
|
|
IDDM
|
[NCBI]
|
1.19777e-06
|
|
|
HBA1
|
[NCBI]
|
1.1443e-06
|
|
|
INS
|
[NCBI]
|
1.06264e-06
|
|
|
ADA
|
[NCBI]
|
1.00943e-06
|
|
|
CP
|
[NCBI]
|
8.02643e-07
|
|
|
APOB
|
[NCBI]
|
7.38284e-07
|
|
|
HD
|
[NCBI]
|
5.33541e-07
|
|
|
CFTR
|
[NCBI]
|
4.32639e-07
|
|
|
CTGF
|
[NCBI]
|
1.95972e-07
|
|
|
WAS
|
[NCBI]
|
1.07564e-07
|
|
|
TTR
|
[NCBI]
|
1.87154e-08
|
|